PHLDB2, or Pleckstrin Homology-Like Domain, Family B, Member 2, is a protein encoded by the PHLDB2 gene in humans. It belongs to a family of proteins known for containing Pleckstrin homology (PH) domains, which are important for their role in intracellular signaling processes. The PH domain facilitates the interaction of PHLDB2 with phosphoinositides and proteins with kinase activity, implicating it in a variety of cellular mechanisms, including signal transduction, cellular organization, and cell migration.Although the full scope of PHLDB2's function is not completely understood, it is believed to be involved in the regulation of cytoskeletal dynamics, contributing to cell shape and motility. This is particularly relevant in the context of neural development and cancer, where cell movement is crucial. There is evidence suggesting that PHLDB2 might have implications in glioma cell migration, indicating a potential role in tumor progression and metastasis.
Moreover, PHLDB2 is thought to be a part of cellular pathways that respond to external stimuli, such as growth factors, which are essential for various aspects of cell growth and survival. Its expression patterns are also of interest in the study of metabolic disorders and diabetes, as PH domain-containing proteins can be involved in insulin signaling and glucose metabolism.Further research into PHLDB2 may uncover more about its involvement in these vital processes and could provide insights into how its dysregulation may contribute to disease states. Understanding PHLDB2's function and regulation could also highlight new strategies for diseases related to cell motility and signaling, such as cancer and metabolic syndromes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that might modify cell survival and signaling pathways, potentially influencing PHLDB2 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Another MEK inhibitor, potentially altering the MAPK/ERK pathway and influencing PHLDB2 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that could influence PHLDB2 expression by altering cell growth and survival pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially affecting cellular stress responses and PHLDB2 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which might alter stress response pathways and PHLDB2 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, potentially leading to cellular stress responses that upregulate PHLDB2 expression. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Induces ER stress and could modulate cell signaling pathways, affecting PHLDB2 expression. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Induces metabolic stress by inhibiting glycolysis, which could lead to changes in PHLDB2 expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Inhibits NF-κB activation, which could modify immune responses and potentially affect PHLDB2 expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can influence NF-κB signaling, possibly impacting PHLDB2 expression. | ||||||